Skip to main content

News & Announcements

Genetic clues found for cognitive resilience to Alzheimer’s disease

Experts discuss knowledge gaps on potential risks for researchers working with Alzheimer’s disease samples

Video games show potential in improving key aspects of memory in older adults

Los NIH amplían un estudio a gran escala sobre biomarcadores de la enfermedad de Alzheimer

NIH augments large scale study of Alzheimer’s disease biomarkers

NIH expands nation’s Alzheimer’s and related dementias research capacity

First tau biomarker approved as an Alzheimer’s disease diagnostic tool

Additional study points to potential promise of plasma NfL as a biomarker for familial Alzheimer’s disease

Better executive function predicts less mobility decline after a fall

Shape and cell type matter for the spread of tau tangles in mouse brain

NIA program staff will answer questions at Alzheimer's Association International Conference virtual booth

NIH Alzheimer’s Disease and Related Dementias Professional Judgment Budget for FY 2022 now online

People with Down syndrome and Alzheimer’s show similar changes in metabolic processes as people with late stage disease

Small RNA regulates tau-related disease sex-differences in mouse models

Mouse study shows microglia not just trash disposal, but essential to healthy neuron balance

Combination of healthy lifestyle traits may substantially reduce Alzheimer’s disease risk

Researchers test new approaches to prevent delirium in older adults

Higher levels of education may help preserve memory in the face of accumulating age-related brain pathology

Alzheimer’s gene contributes to blood-brain barrier breakdown

APOE ε2 gene variant packs protective punch against Alzheimer’s disease

Retina study eyes Alzheimer’s processes to target for early screening

Blocking cellular receptor stops spread of tau in mouse brains

Two views on Alzheimer's biomarkers: Eyeing changes in vision or pupils

Large-scale analysis links glucose metabolism proteins in the brain to Alzheimer's disease biology

Alzheimer's trial screening data links high amyloid levels with early stage disease